1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > The Global Market for Stem Cells

The Global Market for Stem Cells

  • May 2016
  • -
  • BCC Research
  • -
  • 179 pages

This BCC Research report provides implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and important national markets. Sales forecasts are provided from 2016 through 2021.

Use this report to:

Quantify and qualify the stem cell research market for prescription drug products.
Receive information about implications of stem cell research and commercial trends.
Understand how the regulatory environment, healthcare policies, demographics, and other factors directly affect the stem cell-related drug market.
Learn about the nature and structure of the stem cell industry along with profiles of the leading companies.

Highlights
The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1% from 2016 through 2021.
The Americas stem cell market should reach $2.3 billion in 2016 and $4.1 billion by 2021, with a CAGR of 12.1% through 2021.
The Asian stem cell market should reach $1.5 billion in 2016 and $2.9 billion in 2021 at a CAGR of 14.2% through 2021.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products.
Important trends are identified and sales forecasts by product categories and major country markets are provided through 2021; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell–related drug market.
The wider economic environment is also taken into account.
The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.

REASONS FOR DOING THE STUDY

Although products based on stem cells do not yet form an established market, unlike some other potential applications of bioscience, stem cell technology has already produced a number of significant products in important therapeutic areas. This is because the possibilities for successful stem cell therapy are almost beyond estimation, and the urgent need to develop this field is overriding the established, step-by-step approach to proceeding from basic science to practical applications. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.

SCOPE OF REPORT

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.


Table Of Contents

The Global Market for Stem Cells
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 2
MARKET ANALYSES AND FORECASTS 2
METHODOLOGY 3
INTENDED AUDIENCE 3
INFORMATION SOURCES 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 3
BCC RESEARCH WEBSITE 3
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
DEFINITIONS 6
APPLICATIONS 6
RESEARCH AND COMMERCIALIZATION 6
FUNDING 7
MARKET 7
SUMMARY TABLE GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($
MILLIONS) 8
SUMMARY FIGURE GLOBAL STEM CELL MARKET BY REGION, 2014-2021 ($
MILLIONS) 8
CHAPTER 3 OVERVIEW 10
CELLS 10
STEM CELLS 10
FIGURE 1 EARLY DEVELOPMENT OF EMBRYO 10
INDUCED PLURIPOTENT STEM CELLS 13
Mesenchymal Stem Cells 14
hpSCS 14
THE CANCER PROBLEM 15
CANCER STEM CELLS-A WIDER TOPIC 15
CHAPTER 4 STEM CELL RESEARCH 19
HISTORY 19
EMBRYONIC STEM CELLS 20
Growth and Identification of ESCs 20
Stimulating ESCs to Differentiate 21
NEW CELL LINE 21
ADULT STEM CELLS 22
Mesenchymal Stem Cells (MSCs) 22
Hematopoietic Stem Cells (HSCs) 23
Neural Stem Cells (NSCs) 23
Endothelial Progenitor Cells (EPCs) 23
Epithelial Stem Cells (ESCs) 23
Very Small Embryonic-Like Cells (VSELs) 23
CORD BLOOD STEM CELLS 23
INDUCED PLURIPOTENT STEM CELLS (IPSCS) 24
Nuclear Reprogramming 25
CELL-BASED THERAPEUTICS 25
EMBRYONIC-DERIVED STEM CELLS 25
ADULT/PROGENITOR-DERIVED STEM CELLS 26
ENGINEERED SCS FOR TRANSPLANTATION 26
THERAPEUTIC STEM CELL BANKING 27
STEM CELL-BASED BIOMEDICAL RESEARCH 28
REGULATION OF STEM CELL RESEARCH 32
NATIONAL REGULATORY MEASURES 32
Australia 32
Brazil 33
Canada 33
China 33
France 34
Germany 35
India 35
Ireland 35
Israel 36
Italy 36
Japan 36
South Korea 36
Spain 37
Sweden 37
United Kingdom 37
United States 37
California 38
Massachusetts 38
Michigan 38
New Jersey 38
New York 38
FDA Approach 38
EUROPEAN UNION 39
PRACTICALITIES OF STEM CELL RESEARCH AND PRODUCTION 39
STEM CELL PRODUCTION 39
STEM CELL ACQUISITION 40
Characterization and Expansion 40
Maintenance and Storage 41
STEM CELL PRODUCTION ECONOMICS 42
Customized Therapy 42
Banks 43
NOVEL STEM CELL PRODUCTION DEVELOPMENTS 44
ISOLATION AND ENGINEERING 44
Adult Stem Cells 44
Embryonic Stem Cells 45
Induced Pluripotent Stem Cells 47
STEM CELL BANKING 48
ISCBI PROJECT 48
TABLE 1 COUNTRIES ENGAGED IN THE ISCBI PROGRAM 49
FUTURE PERSPECTIVE: THE RISE OF THE ORGANOIDS 50
CHAPTER 5 STEM CELL APPLICATIONS 52
REGENERATIVE MEDICINE 52
CURRENT APPLICATIONS OF STEM CELL THERAPY 55
CANCER 55
Hematopoiesis (Blood Cell Formation) 55
AMYOTROPHIC LATERAL SCLEROSIS 56
PARKINSON'S DISEASE 57
SPINAL CORD INJURY 59
ALZHEIMER'S DISEASE 60
STROKE 61
HEART DISEASE 63
Doubts Expressed 66
PERIPHERAL ARTERIAL DISEASE 66
TYPE 1 DIABETES 68
ORTHOPEDIC REPAIR 70
LIVER FAILURE 70
GRAFT-VERSUS-HOST DISEASE 71
LUNG DISEASE 72
STATUS OF STEM CELL CLINICAL TRIALS 73
Prochymal-stem Cell Therapy 73
Prochymal-Crohn's Disease and Gastrointestinal Injury from
Radiation 74
Mesenchymal Precursor Cell (MPC) Product-Stem Cell Therapy
(Orphan Drug) 74
MyoCell-Stem Cell Therapy 74
ixmyelocel-T-Stem Cell Therapy (Fast Track) 74
StemEx (carlecortemcel-L)-Stem Cell Therapy (Orphan Drug) (Fast
Track) 75
GSK 2696273-Stem Cell Therapy 75
Adult Autologous Stem Cell Therapy (Renew)-Stem Cell Therapy 76
CHAPTER 6 STEM CELL PATENTS 78
GENERAL BACKGROUND ON PATENTS 78
STEM CELL PATENTS 79
PATENTABILITY OF STEM CELL LINES 79
INDIVIDUAL COUNTRY POLICIES 80
UNITED STATES 80
CANADA 80
EPC 80
UNITED KINGDOM 80
GERMANY 81
JAPAN 81
CHINA 81
iPS Cells 81
TABLE 2 IPS-RELATED PATENTS (YAMANAKA, 2011) 82
TABLE 3 CLASSIFICATION OF STEM CELL PATENTS 83
CHAPTER 7 STEM CELL MARKETS 85
MARKETS FOR STEM CELLS 85
MARKET DRIVERS 85
Healthcare 85
TABLE 4 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES 87
Market Restraints 88
Biotechnology 89
Pharmaceutical 90
MARKET OPPORTUNITIES BY THERAPEUTIC CLASS 91
CANCER 91
Other Cancers 91
CARDIOVASCULAR DISEASE 92
Myocardial Infarction 93
TABLE 5 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD 94
CENTRAL NERVOUS SYSTEM DISEASE 95
Spinal Cord Injury (SCI) 95
TABLE 6 STATISTICS FOR SCI IN THE U.S., 2014 96
Neurodegenerative Diseases 97
TABLE 7 NEURODEGENERATIVE DISEASES WORLDWIDE, 2015 97
DIABETES MELLITUS 98
TABLE 8 STATISTICS FOR DIABETES IN THE U.S., 2014 98
TABLE 9 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES,
THROUGH 2021 ($ BILLIONS) 99
SKELETAL SYSTEM 100
GLOBAL MARKET ESTIMATES AND FORECASTS 101
TABLE 10 GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS) 101
REGIONAL AND NATIONAL MARKET ANALYSIS 101
AMERICAS 101
TABLE 11 AMERICAS STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($
MILLIONS) 101
U.S. 102
TABLE 12 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES 102
TABLE 13 U.S. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 103
TABLE 14 U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 104
TABLE 15 U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 104
Canada 104
TABLE 16 CANADA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 105
TABLE 17 CANADA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 105
TABLE 18 CANADA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021
($ MILLIONS) 106
Brazil 106
TABLE 19 BRAZIL STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 107
TABLE 20 BRAZIL STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 107
TABLE 21 BRAZIL STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 107
Mexico 108
TABLE 22 MEXICO STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 108
TABLE 23 MEXICO STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 108
EUROPE 109
TABLE 24 EUROPE STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS) 109
Market Opportunities by Disease Category 110
TABLE 25 STATISTICS FOR CVD IN EUROPE, 2012 110
TABLE 26 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN
COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES) 110
TABLE 27 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013 111
TABLE 28 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT
EUROPEAN COUNTRIES, 2011 111
TABLE 29 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN
COUNTRIES, 2013 112
France 112
TABLE 30 FRANCE STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 112
TABLE 31 FRANCE STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 113
TABLE 32 FRANCE STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 113
Germany 113
TABLE 33 GERMANY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 114
TABLE 34 GERMANY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH
2021 ($ MILLIONS) 114
TABLE 35 GERMANY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021
($ MILLIONS) 114
Italy 114
TABLE 36 ITALY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 115
TABLE 37 ITALY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 115
TABLE 38 ITALY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 116
Spain 116
TABLE 39 SPAIN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 117
TABLE 40 SPAIN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 117
TABLE 41 SPAIN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 117
United Kingdom 118
TABLE 42 U.K. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 119
TABLE 43 U.K. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 119
TABLE 44 U.K. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 119
ASIA 119
Market Opportunities by Disease Category 119
TABLE 45 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011 120
TABLE 46 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES 120
TABLE 47 ASIA STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS) 121
Japan 121
TABLE 48 JAPAN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 123
TABLE 49 JAPAN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 123
TABLE 50 JAPAN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 123
China 123
TABLE 51 CHINA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 127
TABLE 52 CHINA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 127
TABLE 53 CHINA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 128
India 128
TABLE 54 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA 129
TABLE 55 INDIA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 129
TABLE 56 INDIA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 130
TABLE 57 INDIA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 130
REST OF WORLD 130
TABLE 58 REST OF WORLD STEM CELL MARKET BY SEGMENT, THROUGH 2021 ($
MILLIONS) 130
CHAPTER 8 COMPANY PROFILES 132
3DMATRIX 133
ALDAGEN INC. 133
ANGIOBLAST SYSTEMS 135
ARTERIOCYTE 136
ATHERSYS INC. 136
BEIKE BIOTECHNOLOGY CO. LTD. 137
BIOTIME INC. 138
BRAINSTORM CELL THERAPEUTICS INC. 139
CALADRIUS BIOSCIENCES INC. 140
CAPRICOR INC. 141
CELLERANT THERAPEUTICS INC. 142
CELLERIX SA 143
CELLULAR DYNAMICS INTERNATIONAL 144
CELYAD 145
CLONTECH 145
CYTORI THERAPEUTICS INC. 146
EPISTEM LTD. 148
GAMIDA CELL LTD. 148
GLOBALSTEM 149
HYBRID ORGAN GMBH 150
INTELLICELL BIOSCIENCES INC. 151
INTERNATIONAL STEM CELL CORP. 151
JUVENTAS THERAPEUTICS INC. 153
MESOBLAST LTD. 153
NEURALSTEM 155
NEUROGENERATION 156
OCATA 156
OSIRIS THERAPEUTICS INC. 157
PRIMEGEN BIOTECH LLC 158
RENEURON GROUP 158
RHINOCYTE INC. 160
STEM CELLS INC. 160
STEMCELL TECHNOLOGIES SARL 161
STEM CELL THERAPEUTICS CORP. 162
STEMEDICA CELL TECHNOLOGIES INC. 163
STEMINA BIOMARKER DISCOVERY INC. 164
STEMPEUTICS RESEARCH PVT. LTD. 165
TIGENIX NV 166
U.S. STEM CELL 167
VERASTEM INC. 168
VERICEL 169
VERISTEM TECHNOLOGIES 169
VIACYTE 170
VITRO DIAGNOSTICS INC. 171
WICELL RESEARCH INSTITUTE 172
XPAND BIOTECHNOLOGY BV 173
CHAPTER 9 GLOSSARY 175
CHAPTER 10 SIGNIFICANT STEM CELL RESEARCH PATENTS 182
TABLE 59 SIGNIFICANT STEM CELL RESEARCH PATENTS 182

LIST OF TABLES

SUMMARY TABLE GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($
MILLIONS) 8
TABLE 1 COUNTRIES ENGAGED IN THE ISCBI PROGRAM 49
TABLE 2 IPS-RELATED PATENTS (YAMANAKA, 2011) 82
TABLE 3 CLASSIFICATION OF STEM CELL PATENTS 83
TABLE 4 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES 87
TABLE 5 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD 94
TABLE 6 STATISTICS FOR SCI IN THE U.S., 2014 96
TABLE 7 NEURODEGENERATIVE DISEASES WORLDWIDE, 2015 97
TABLE 8 STATISTICS FOR DIABETES IN THE U.S., 2014 98
TABLE 9 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES,
THROUGH 2021 ($ BILLIONS) 99
TABLE 10 GLOBAL STEM CELL MARKET BY REGION, THROUGH 2021 ($ MILLIONS) 101
TABLE 11 AMERICAS STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS) 101
TABLE 12 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES 102
TABLE 13 U.S. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 103
TABLE 14 U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 104
TABLE 15 U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 104
TABLE 16 CANADA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 105
TABLE 17 CANADA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 105
TABLE 18 CANADA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 106
TABLE 19 BRAZIL STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 107
TABLE 20 BRAZIL STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 107
TABLE 21 BRAZIL STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 107
TABLE 22 MEXICO STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 108
TABLE 23 MEXICO STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 108
TABLE 24 EUROPE STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS) 109
TABLE 25 STATISTICS FOR CVD IN EUROPE, 2012 110
TABLE 26 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN
COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES) 110
TABLE 27 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013 111
TABLE 28 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN
COUNTRIES, 2011 111
TABLE 29 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN
COUNTRIES, 2013 112
TABLE 30 FRANCE STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 112
TABLE 31 FRANCE STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 113
TABLE 32 FRANCE STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 113
TABLE 33 GERMANY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 114
TABLE 34 GERMANY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021
($ MILLIONS) 114
TABLE 35 GERMANY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021
($ MILLIONS) 114
TABLE 36 ITALY STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 115
TABLE 37 ITALY STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 115
TABLE 38 ITALY STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 116
TABLE 39 SPAIN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 117
TABLE 40 SPAIN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 117
TABLE 41 SPAIN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 117
TABLE 42 U.K. STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 119
TABLE 43 U.K. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 119
TABLE 44 U.K. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 119
TABLE 45 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011 120
TABLE 46 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES 120
TABLE 47 ASIA STEM CELL MARKET BY COUNTRY, THROUGH 2021 ($ MILLIONS) 121
TABLE 48 JAPAN STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 123
TABLE 49 JAPAN STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 123
TABLE 50 JAPAN STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 123
TABLE 51 CHINA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 127
TABLE 52 CHINA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 127
TABLE 53 CHINA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 128
TABLE 54 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA 129
TABLE 55 INDIA STEM CELL THERAPY MARKET, THROUGH 2021 ($ MILLIONS) 129
TABLE 56 INDIA STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 130
TABLE 57 INDIA STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2021 ($
MILLIONS) 130
TABLE 58 REST OF WORLD STEM CELL MARKET BY SEGMENT, THROUGH 2021 ($
MILLIONS) 130
TABLE 59 SIGNIFICANT STEM CELL RESEARCH PATENTS 182
BIO035F - The Global Market for Stem Cells
SUMMARY FIGURE GLOBAL STEM CELL MARKET BY REGION, 2014-2021 ($ MILLIONS) 8
FIGURE 1 EARLY DEVELOPMENT OF EMBRYO 10

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Stem-cell therapy medical practice which is used to treat or prevent a disease or condition using stem cells.Recent inventions and R&D activities have shown that stem cells have tremendous promise to help ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.